{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hypothyroidism/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"09adb285-1d01-592a-9443-295b45c7d78b","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 0369bfb6-a39f-4f93-8cc5-5de6c9b48f0b --><h2>How common is it?</h2><!-- end field 0369bfb6-a39f-4f93-8cc5-5de6c9b48f0b -->","summary":"","htmlStringContent":"<!-- begin item 48a3f288-9ae7-48a5-9486-6aa382ea9edd --><!-- begin field 6ed7e23b-b45b-4942-a865-573454670686 --><p><strong>The prevalence of hypothyroidism in the literature varies according to the definition used, the population characteristics, and the geographical area studied </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>]<strong>.</strong></p><ul><li><strong>Primary hypothyroidism</strong><ul><li>In areas where dietary iodine is adequate, such as the UK, the prevalence of spontaneous hypothyroidism is 1–2%. It is up to 10 times more common in women than in men [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Vanderpump, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Ingoe, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Mendes, 2019</a>].</li><li>A meta-analysis of 17 European studies of thyroid dysfunction found that [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Madariaga et al, 2014</a>]:<ul><li>The total prevalence (diagnosed and undiagnosed) of hypothyroidism was 3%.</li><li>The prevalence of undiagnosed hypothyroidism was 4.9% (6.4% in females and 3.4% in males). Of these, the prevalence of overt hypothyroidism was 0.8% in females and 0.3% in males, and the prevalence of subclinical hypothyroidism was 5.9% in females and 3.4% in males.</li><li>The incidence rate of hypothyroidism was 226.2 per 100,000 people per year; 370 per 100,000 per year in women and 72.5 per 100,000 per year in men.</li></ul></li><li>A review article notes that the prevalence of overt hypothyroidism in Europe varies between 0.2–5.3%, depending on the definition of hypothyroidism used [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>].</li><li>A retrospective analysis of General Practice data in the North East of England (n = 66,843) found the overall single-point prevalence of treated hypothyroidism was 4.5% in 2016 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Ingoe, 2017</a>].<ul><li>The prevalence increased with increasing age.</li></ul></li><li>A review of UK national databases found the prevalence of treated hypothyroidism increased from 2.3% (1.4 million) to 3.5% (2.2 million) of the total UK population between 2005 and 2014 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Razvi, 2019</a>].<ul><li>There was large geographical variation of treated hypothyroidism across the UK, with London having the lowest (1.4%) and the Western Isles of Scotland having the highest (6.3%) prevalence.</li><li>The prevalence of treated hypothyroidism was positively associated with female sex, White ethnicity, and obesity.</li></ul></li><li>A meta-analysis of 20 European studies found the estimated prevalence of undiagnosed overt hypothyroidism was 0.65% and undiagnosed subclinical hypothyroidism was 4.11% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Mendes, 2019</a>].<ul><li>The authors noted, however, high heterogeneity between studies regarding study design, populations studied, sample size, diagnostic tests, and reference ranges used.</li></ul></li><li>The British Thyroid Association (BTA) notes that subclinical hypothyroidism affects 5–10% of the population [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Okosieme, 2015</a>].<ul><li>The prevalence increases in women and with increasing age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Peeters, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Biondi, 2019</a>]. </li></ul></li><li>The true prevalence of subclinical hypothyroidism may have been over-estimated in older people (over the age of 70 years, for example), due to the physiological increase in TSH levels with increasing age, that may be misinterpreted as thyroid disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Biondi, 2019</a>].</li></ul></li><li><strong>Secondary hypothyroidism</strong><ul><li>Secondary hypothyroidism is rare. The estimated incidence varies between 1 per 20,000 and 1 per 80,000 people in the general population [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Hershman, 2013</a>].</li></ul></li><li><strong>Pregnanc</strong><strong>y</strong><ul><li>The European Thyroid Association (ETA) guidelines state that the prevalence of [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Lazarus et al, 2014</a>]:<ul><li>Overt hypothyroidism in pregnancy is 0.2–0.5%.</li><li>Subclinical hypothyroidism in pregnancy is 2–2.5%.</li></ul></li></ul></li><li><strong>Postpartum thyroiditis (PPT)</strong><ul><li>The Endocrine Society states the prevalence of PPT in iodine-sufficient areas is about 7% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">De Groot et al, 2012</a>].</li><li>The American Thyroid Association (ATA) guideline states that the prevalence of PPT is about 5%, although it notes that estimates vary in the literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Alexander, 2017</a>].</li></ul></li></ul><!-- end field 6ed7e23b-b45b-4942-a865-573454670686 --><!-- end item 48a3f288-9ae7-48a5-9486-6aa382ea9edd -->","topic":{"id":"f1d76bc1-c8dd-515b-a709-48c70c829658","topicId":"ebfc5032-6653-4b11-895c-5080f933e861","topicName":"Hypothyroidism","slug":"hypothyroidism","lastRevised":"Last revised in August 2020","chapters":[{"id":"cf0a606b-f582-5671-a84d-a1a3a12b7180","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"795eb9d9-4e15-51f6-81f4-7cc1b69ca74e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a8d7a846-dfa6-5db5-ba95-fb161fd48c6e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d8567cc1-0642-5e9e-ad6c-8ca4abf5fa6e","slug":"changes","fullItemName":"Changes"},{"id":"c5e99cd1-e0c7-5efd-84bb-15bac6122b1d","slug":"update","fullItemName":"Update"}]},{"id":"2b8464ae-3182-517a-85be-6acc656616c5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"17d5ebf3-bdca-50d2-a4f5-245d191f4973","slug":"goals","fullItemName":"Goals"},{"id":"9162c6a3-edc4-5319-9418-04b2cb656ce6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2ae5c1d9-638e-52fa-b738-9561cd11b0ab","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7fec82ae-e144-56a7-b1e8-8744c35e227e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"610f052f-83a2-5b06-b5e6-4aa272ef73a6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a578bde3-0d84-54f7-814d-18ed38e6038a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"66bb9b4f-4de2-5da7-aba1-ec9bff4b2454","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"4b8f382f-673d-5804-8291-438e21e32790","slug":"definition","fullItemName":"Definition"},{"id":"ef0d96cd-207c-5814-93cf-c96870e2251d","slug":"causes","fullItemName":"Causes"},{"id":"09adb285-1d01-592a-9443-295b45c7d78b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9bfb88d8-8d33-53a3-8d0e-1b202457fb2e","slug":"complications","fullItemName":"Complications"},{"id":"5ff1ef9f-bb77-5feb-bd5a-12d7b43cca9d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"cfe582c4-479a-5d44-b893-ac46a1a80b29","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6884c3db-6165-566b-a4ca-3e933de77714","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"42799fb8-7252-541e-9af1-27ebc28710b7","slug":"assessment","fullItemName":"Assessment"},{"id":"e850b740-b6cf-55a7-aed8-7372b7f13b05","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"d817ab4c-e7a3-582a-94fa-fcffd9c2d4f6","slug":"screening","fullItemName":"Screening"}]},{"id":"b377a2c4-68d7-573f-912f-123b99d0aba1","fullItemName":"Management","slug":"management","subChapters":[{"id":"daacd844-c78f-5626-a2ea-93077f98f729","slug":"overt-hypothyroidism-non-pregnant","fullItemName":"Scenario: Overt hypothyroidism (non-pregnant)"},{"id":"e358d249-a2f3-5a06-b301-2119af9ae164","slug":"subclinical-hypothyroidism-non-pregnant","fullItemName":"Scenario: Subclinical hypothyroidism (non-pregnant)"},{"id":"9e4d552e-5fb3-571b-b14a-fec340b943f0","slug":"preconception-or-pregnant","fullItemName":"Scenario: Preconception or pregnant"},{"id":"611f3939-9d39-5545-b225-f9b33fdb095e","slug":"postpartum","fullItemName":"Scenario: Postpartum"}]},{"id":"7b2d6d51-4029-5c06-8789-30e0056076fa","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ee5ac1fb-6ba7-5e52-9861-d62637c03bf0","slug":"levothyroxine","fullItemName":"Levothyroxine"}]},{"id":"2aaf1754-ba79-5b47-b2a5-74fe8f6af4da","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7669c894-3a85-55c7-b689-cb4b710a838a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"840d7de5-8c31-5696-9de6-c80ce1bbfec7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"299c20bf-2a22-5681-99ad-5f02f1395969","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"dd3df39b-4a5c-5416-af8d-dcdbf46bd255","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a88d4431-778a-5793-9557-9f806339a95b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1987302d-f600-55e0-a528-d3486c49048e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a49e5d2f-75e4-5219-a4d6-fd4a5595a776","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"66bb9b4f-4de2-5da7-aba1-ec9bff4b2454","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}